EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities

Filomena Napolitano iD, Francesca Wanda Rossi iD, Amato de Paulis iD, Antonio Lavecchia iD, Nunzia Montuori iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25063156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Filomena Napolitano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences, University of Naples Federico II, 80138 Naples, Italy. Hauptthemen laut MEDLINE: Receptors, Formyl Peptide, Scleroderma, Systemic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN 2022 PNRR, Settore ERC: LS4.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic Sclerosis (SSc) is a heterogeneous autoimmune disease characterized by widespread vasculopathy, the presence of autoantibodies and the progressive fibrosis of skin and visceral organs. There are still many questions about its pathogenesis, particularly related to the complex regulation of the fibrotic process, and to the factors that trigger its onset. Our recent studies supported a key role of N-formyl peptide receptors (FPRs) and their crosstalk with uPAR in the fibrotic phase of the disease. Here, we found that dermal fibroblasts acquire a proliferative phenotype after the activation of FPRs and their interaction with uPAR, leading to both Rac1 and ERK activation, c-Myc phosphorylation and Cyclin D1 upregulation which drive cell cycle progression. The comparison between normal and SSc fibroblasts reveals that SSc fibroblasts exhibit a higher proliferative rate than healthy control, suggesting that an altered fibroblast proliferation could contribute to the initiation and progression of the fibrotic process. Finally, a synthetic compound targeting the FPRs/uPAR interaction significantly inhibits SSc fibroblast proliferation, paving the way for the development of new targeted therapies in fibrotic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Formyl PeptideScleroderma, SystemicHumansFibrosisFibroblastsAutoantibodiesSkinCells, Cultured

Stichwörter der Autor:innen

N-formyl peptide receptorsfibroblast proliferationsmall moleculessystemic sclerosisurokinase receptor

Substanzen

Receptors, Formyl PeptideAutoantibodies

Autor:innen und Institutionen

  • Department of Translational Medical Sciences, University of Naples Federico II, 80138 Naples, Italy.
  • Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, 80131 Naples, Italy.
  • "Drug Discovery" Laboratory, Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.

ORCID-Profile: Filomena Napolitano, Francesca Wanda Rossi, Amato de Paulis, Antonio Lavecchia, Nunzia Montuori

Förderung

  • PRIN 2022 PNRR, Settore ERC: LS4

Zitieren

APA

Napolitano, F., Rossi, F. W., de Paulis, A., Lavecchia, A., & Montuori, N. (2024). The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063156

Vancouver

Napolitano F, Rossi FW, de Paulis A, Lavecchia A, Montuori N. The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063156

BibTeX
@article{Napolitano2024,
  author = {Napolitano, Filomena and Rossi, Francesca Wanda and de Paulis, Amato and Lavecchia, Antonio and Montuori, Nunzia},
  title = {The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25063156}
}
Kostenlos starten →